Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders

Today, there is no reliable pharmacological correction of dementia, despite its high prevalence worldwide. The clinical presentation of Alzheimer's disease at one or another stage is accompanied by neuropsychiatric disorders (NPDs) in addition to cognitive defect. The intensity and range of NPD...

Full description

Bibliographic Details
Main Author: E. G. Mendelevich
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2018-11-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/961
id doaj-1ac906d1843d41fc85337f5dbdeda314
record_format Article
spelling doaj-1ac906d1843d41fc85337f5dbdeda3142021-07-29T08:58:39ZrusIMA-PRESS LLCNevrologiâ, Nejropsihiatriâ, Psihosomatika2074-27112310-13422018-11-0110312913410.14412/2074-2711-2018-3-129-134775Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disordersE. G. Mendelevich0Kazan State Medical University, Kazan, Republic of Tatarstan, Russia 49, Butlerov St., Kazan, Republic of TatarstanToday, there is no reliable pharmacological correction of dementia, despite its high prevalence worldwide. The clinical presentation of Alzheimer's disease at one or another stage is accompanied by neuropsychiatric disorders (NPDs) in addition to cognitive defect. The intensity and range of NPDs are different. The possibilities of drug therapy for NPDs are demonstrated. The role of akatinol memantine in correcting a number of psychological and behavioral disorders is highlighted. Biological, psychological, social, and environmental factors are identified among those that contribute to or provoke the development of NPDs. Knowledge of the triggers of mental disorders makes it possible to prevent and thereby reduce or eliminate NPDs. Special emphasis is laid on the patient-caregiver relationship. In recent years, non-pharmacological interventions have been increasingly used as priority-line therapy for NPDs. There are data on main methods for non-pharmacological correction and on the efficiency of their application.https://nnp.ima-press.net/nnp/article/view/961alzheimer's diseasedementianeuropsychiatric disorderspharmacological and non-pharmacological correctionakatinol memantine
collection DOAJ
language Russian
format Article
sources DOAJ
author E. G. Mendelevich
spellingShingle E. G. Mendelevich
Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
Nevrologiâ, Nejropsihiatriâ, Psihosomatika
alzheimer's disease
dementia
neuropsychiatric disorders
pharmacological and non-pharmacological correction
akatinol memantine
author_facet E. G. Mendelevich
author_sort E. G. Mendelevich
title Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
title_short Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
title_full Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
title_fullStr Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
title_full_unstemmed Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
title_sort alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
publisher IMA-PRESS LLC
series Nevrologiâ, Nejropsihiatriâ, Psihosomatika
issn 2074-2711
2310-1342
publishDate 2018-11-01
description Today, there is no reliable pharmacological correction of dementia, despite its high prevalence worldwide. The clinical presentation of Alzheimer's disease at one or another stage is accompanied by neuropsychiatric disorders (NPDs) in addition to cognitive defect. The intensity and range of NPDs are different. The possibilities of drug therapy for NPDs are demonstrated. The role of akatinol memantine in correcting a number of psychological and behavioral disorders is highlighted. Biological, psychological, social, and environmental factors are identified among those that contribute to or provoke the development of NPDs. Knowledge of the triggers of mental disorders makes it possible to prevent and thereby reduce or eliminate NPDs. Special emphasis is laid on the patient-caregiver relationship. In recent years, non-pharmacological interventions have been increasingly used as priority-line therapy for NPDs. There are data on main methods for non-pharmacological correction and on the efficiency of their application.
topic alzheimer's disease
dementia
neuropsychiatric disorders
pharmacological and non-pharmacological correction
akatinol memantine
url https://nnp.ima-press.net/nnp/article/view/961
work_keys_str_mv AT egmendelevich alzheimersdiseasesomepharmacologicalandnonpharmacologicalapproachestocorrectingneuropsychiatricdisorders
_version_ 1721250571680219136